Review article: Managing bone complications after kidney transplantation

Nephrology

Volumn 14, Issue 4, 2009, Pages 437-442

  Mainra, Rahul ^a   Elder, Grahame ^b,c  

^a Saskatoon Health Region St Pauls Hospital   (Canada)

^b WESTMEAD HOSPITAL   (Australia)

^c GARVAN INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

Algorithm; Bisphosphonate; Bone mineral density; Bone turnover; Calcitriol; Kidney transplant

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; CALCITONIN; CALCITRIOL; GLUCOCORTICOID; PARATHYROID HORMONE; VITAMIN D;

BONE DENSITY; BONE MINERALIZATION; BONE RADIOGRAPHY; BONE TURNOVER; CHRONIC KIDNEY DISEASE; DUAL ENERGY X RAY ABSORPTIOMETRY; FRACTURE; HUMAN; HYPERCALCEMIA; HYPERPARATHYROIDISM; KIDNEY TRANSPLANTATION; LABORATORY TEST; PRIORITY JOURNAL; QUALITY OF LIFE; RENAL OSTEODYSTROPHY; REVIEW; RISK FACTOR;

BONE DENSITY; BONE DISEASES; HUMANS; KIDNEY TRANSPLANTATION; POSTOPERATIVE COMPLICATIONS; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS;

EID: 67650757648     PISSN: 13205358     EISSN: 14401797     Source Type: Journal    
DOI: 10.1111/j.1440-1797.2009.01156.x     Document Type: Review

References (33)

1. Monier-faugere MC, Mawad H, Qi Q, Friedler RM, Malluche HH. High prevalence of low bone turnover and occurrence of osteomalacia after kidney transplantation. J. Amer. Soc. Nephrology 2000 11 : 1093 9.
2. Rojas E, Carlini R, Clesca P et al. The pathogenesis of osteodystrophy after renal transplantation as detected by early alterations in bone remodeling. Kidney Int. 2003 63 : 1915 23.
3. Julian BA, Laskow DA, Dubovsky J, Dubovsky EV, Curtis JJ, Quarles LD. Rapid loss of vertebral mineral density after renal transplantation. N. Engl. J. Med. 1991 325 : 544 50.
4. Casez JP, Lippuner K, Horber FF, Montandon A, Jaeger P. Changes in bone mineral density over 18 months following kidney transplantation: The respective roles of prednisone and parathyroid hormone. Nephrol. Dial. Transpl. 2002 17 : 1318 26.
5. Mikuls TR, Julian BA, Bartolucci A, Saag KG. Bone mineral density changes within six months of renal transplantation. Transplantation 2003 75 : 49 54. (Pubitemid 36139694)
6. Brandenburg VM, Politt D, Ketteler M et al. Early rapid loss followed by long-term consolidation characterizes the development of lumbar bone mineral density after kidney transplantation. Transplantation 2004 77 : 1566 71.
7. Marcen R, Caballero C, Pascual J et al. Lumbar bone mineral density in renal transplant patients on neoral and tacrolimus: A four-year prospective study. Transplantation 2006 81 : 826 31.
8. Durieux S, Mercadal L, Orcel P et al. Bone mineral density and fracture prevalence in long-term kidney graft recipients. Transplantation 2002 74 : 496 500. (Pubitemid 34977678)
9. Alem AM, Sherrard DJ, Gillen DL et al. Increased risk of hip fracture among patients with end-stage renal disease. Kidney Int. 2000 58 : 396 9.
10. Stehman-Breen CO, Sherrard DJ, Alem AM et al. Risk factors for hip fracture among patients with end-stage renal disease. Kidney Int. 2000 58 : 2200 5.
11. Ball AM, Gillen DL, Sherrard D et al. Risk of hip fracture among dialysis and renal transplant recipients. JAMA. 2002 288 : 3014 18.
12. Ramsey-Goldman R, Dunn JE, Dunlop DD et al. Increased risk of fracture in patients receiving solid organ transplants. J. Bone Miner. Res. 1999 14 : 456 63.
13. Elder G, Mackun K. 25-Hydroxyvitamin D deficiency and diabetes predict reduced bone mineral density in patients with chronic kidney disease. J. Bone Miner. Res. 2006 21 : 1778 84.
14. Jamal SA, Hayden JA, Beyene J. Low bone mineral density and fractures in long-term hemodialysis patients: A meta-analysis. Am. J. Kidney Dis. 2007 49 : 674 81.
15. Vincenti F, Schena FP, Paraskevas S, Hauser IA, Walker RG, Grinyo J. A randomized, multicenter study of steroid avoidance, early steroid withdrawal or standard steroid therapy in kidney transplant recipients. Am. J. Transpl. 2008 8 : 307 16.
16. Farmer CKT, Hampson G, Abbs IC et al. Late low-dose steroid withdrawal in renal transplant recipients increases bone formation and bone mineral density. Am. J. Transpl. 2006 6 : 2929 36.
17. Messa P, Sindici C, Cannella G et al. Persistent secondary hyperparathyroidism after renal transplantation. Kidney Int. 1998 54 : 1704 13.
18. Akaberi S, Lindergard B, Simonsen O, Nyberg G. Impact of parathyroid hormone on bone density in long-term renal transplant patients with good graft function. Clin. Transplantation 2006 82 : 749 52.
19. Cueto-Manzano A, Konel S, Hutchison AJ et al. Bone loss in long-term renal transplantation: Histopathology and densitometry analysis. Kidney Int. 1999 55 : 2021 9.
20. Adachi JD, Ioannidis G, Berger C et al. The influence of osteoporotic fractures on health-related quality of life in community-dwelling men and women across Canada. Osteoporos Int. 2001 12 : 903 8.
21. Kanis JA, Oden A, Johnell O, De Laet C, Jonsson B. Excess mortality after hospitalisation for vertebral fracture. Osteoporos Int. 2004 15 : 108 12.
22. Nitsch D, Mylne A, Roderick P, Smeeth L, Hubbard R, Fletcher A. Chronic kidney disease and hip-fracture-related mortality in older people in the UK. Nephrol Dial Transpl. 2009 24 : 1539 44.
23. Coco M, Rush H. Increased incidence of hip fractures in dialysis patients with low serum parathyroid hormone. Am. J. Kidney Dis. 2000 36 : 1115 21.
24. Abbott KC, Oglesby RJ, Hypolite IO et al. Hospitalizations for fractures after renal transplantation in the United States. Ann. Epidemiol. 2001 11 : 450 57.
25. Lyles KW, Colon-Emeric CS, Magaziner JS et al. Zoledronic acid and clinical fracture and mortality after hip fracture. N. Engl. J. Med. 2007 357 : 1799 809.
26. Jeffery JR, Leslie WD, Karpinski ME, Nickerson PW, Rush DN. Prevalence and treatment of decreased bone density in renal transplant recipients: A randomized prospective trial of calcitriol versus alendronate. Transplantation 2003 76 : 1498 502.
27. Trabulus S, Altiparmak MR, Apaydin S, Serdengecti K, Sariyar M. Treatment of renal transplant recipients with low bone mineral density: A randomized prospective trial of alendronate, alfacalcidol, and alendronate combined with alfacalcidol. Transpl. Proc. 2008 40 : 160 66.
28. Nayak B, Guleria S, Varma M et al. Effect of bisphosphonates on bone mineral density after renal transplantation as assessed by bone mineral densitometry. Transpl. Proc. 2007 39 : 750 52.
29. Nowacka-Cieciura E, Cieciura T, Baczkowska T et al. Bisphosphonates are effective prophylactic of early bone loss after renal transplantation. Transpl. Proc. 2006 38 : 165 7.
30. El-Agroudy AE, El-Husseini AA, El-Sayed M, Mohsen T, Ghoneim MA. A prospective randomized study for prevention of postrenal transplantation bone loss. Kidney Int. 2005 67 : 2039 45.
31. Palmer SC, McGregor D, Strippoli G. Interventions for preventing bone disease in kidney transplant recipients (Review). Cochrane Database of Syst. Rev. 2007 3.
32. Miller P. Is there a role for bisphosphonates in chronic kidney disease? Semin. Dial. 2007 20 : 186 90.
33. Mainra R, Elder G. Application of a treatment algorithm to avoid BMD loss and limit bisphosphonate use after kidney and kidney pancreas transplantation. J. Bone Miner. Res. 2008 23 : SA497.